Vaxart, Inc. (VXRT)
OTCMKTS · Delayed Price · Currency is USD
0.4246
+0.0166 (4.07%)
At close: Oct 29, 2026
Vaxart Employees
Vaxart had 65 employees as of December 31, 2025. The number of employees decreased by 40 or 38.10% compared to the previous year. That makes Vaxart the 33,827th largest employer in the world and 4,459th in the United States.
Employees
65
Change (1Y)
-40
Growth (1Y)
-38.10%
Revenue / Employee
$3,739,462
Profits / Employee
$593,677
Market Cap
103.26M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 65 | -40 | -38.10% |
| Dec 31, 2024 | 105 | -4 | -3.67% |
| Dec 31, 2023 | 109 | -55 | -33.54% |
| Dec 31, 2022 | 164 | 54 | 49.09% |
| Dec 31, 2021 | 110 | 82 | 292.86% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Sangamo Therapeutics | 142 |
| Northwest Biotherapeutics | 105 |
| CytoDyn | 14 |
| Nuo Therapeutics | 10 |
| Cell Source | 1 |
Vaxart News
- 1 day ago - Vaxart to Host Stockholder Fireside Chat on November 6 at 4:30 p.m. ET - GlobeNewsWire
- 11 days ago - Vaxart Appoints Retired Vice Admiral Raquel C. Bono, M.D., to Board of Directors October 19, 2026 08:00 ET | Source: Vaxart, - GlobeNewsWire
- 22 days ago - Vaxart Announces Publication of Preclinical Study Demonstrating 100% Protection Against a Lethal Dose of H5N1 Avian Flu in a Ferret Challenge Model - GlobeNewsWire
- 6 weeks ago - Vaxart Transcript: H.C. Wainwright 28th Annual Global Investment Conference - Transcripts
- 6 weeks ago - Vaxart Slides: H.C. Wainwright 28th Annual Global Investment Conference - Filings
- 7 weeks ago - Vaxart to Present at the H.C. Wainwright 28th Annual Global Investment Conference - GlobeNewsWire
- 2 months ago - Vaxart granted European patent covering oral norovirus vaccine through 2036 - TheFly
- 2 months ago - Vaxart Expands Intellectual Property Portfolio with European Patent Protecting Proprietary Norovirus Vaccine Technology - GlobeNewsWire